Comprehensive Understanding of Readiness for Elimination

Confidential Page | 1

Form Approved

OMB No. 0920-XXXX

Exp. Date XX/XX/20XX

Comprehensive Understanding of Readiness for Elimination of Hepatitis C in Corrections (Cure-HepC)

Public reporting burden of this collection of information varies from 10 to 30 minutes to complete, with an average time to complete of 20 minutes. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-XXXX).

The goal of this survey is to understand practices surrounding hepatitis C virus screening, testing, and treatment.

Each responding system will receive a request to complete this web-based survey. The survey has branching logic to improve efficiency and reduce the time burden for completing this survey. Participating systems will have a set-time period, as determined by the survey team, to complete the survey. The survey will be self-administered. Please answer the survey questions to the best of your ability.

Thank you!

__________________________________

Today’s date

The first set of questions are about your system.

Other, please explain:		__________________________________________
	4. What is the average length of stay (in days) of the confined and/or detained population in your system?	__________________________________ (Please answer in whole numbers)

The next set of questions are about hepatitis C virus (HCV) testing practices within your system

HCV screening consists of testing for the presence of antibodies to HCV, and if reactive, testing for HCV RNA to diagnose current infection.

Reflex testing means automatically performing HCV RNA testing on patients with a reactive

HCV antibody using the same blood sample.

HCV screening may consist of single-step HCV RNA testing for populations with high rates of recent HCV exposure.

________________________________________

(Reflex testing means HCV RNA testing is performed automatically on patients with a positive HCV antibody using the same blood sample)

Other, please explain:

__________________________________________

The next set of questions are about hepatitis C treatment practices within your system.

7. What criteria was utilized to select and prioritize your confined and/or detained population who had hepatitis C infection for treatment? (Please select all that apply).

Length of stay

Blood tests (i.e., liver function test, APRI, FIB-4)

Prescence of co-existing illness

Liver imaging

Age

Participation in substance use treatment or programming

Previous history of hepatitis C treatment

History of discipline and/or incidents during current confinement

None, universal hepatitis C treatment policy

Other

Other, please explain:	__________________________________________
	__________________________________

8. What clinical practice guideline(s) did you use to initiate treatment for your confined and/or detained population for hepatitis C infection? (Please select all that apply).

• American Association for the Study of Liver Diseases

• Federal Bureau of Prisons HCV clinical

• In-house developed HCV clinical guidance

• Patient seen by outside specialist

• Not applicable

• Other

Other, please explain: __________________________________________

__________________________________________

10. Do you offer medication for opioid Yes

use disorder (MOUD) to your confined and/or detained population No

undergoing treatment for hepatitis C infection who have an opioid Other

use disorder?

Other, please explain:

__________________________________________

The next set of questions are about hepatitis C treatment opportunities and barriers within your system.

10. Please identify challenges you have encountered in your efforts to Medication cost

treat your confined and/or detained population who have Medication access

hepatitis C infection. Inadequate nursing

staffing

Laboratory cost

(Please select all that apply). In-house provider access/adequacy

Specialist Provider access/adequacy

Patient non-compliance

Linkage to community providers on discharge

Access to medical services on discharge

No or Inadequate data systems

Length of stay

None of the above

Other

Other, please explain:		__________________________________________
12. What is your single greatest challenge in testing and treating your confined and/or detained population who have hepatitis C infection?		__________________________________________ (Please thoroughly explain)
13. Is there anything else you would like to convey regarding your ability to test and treat hepatitis
regarding your ability to test and treat hepatitis C
infection among your confined and/or detained population?	__________________________________________
	(Please thoroughly explain)